Picture of Larimar Therapeutics logo

LRMR — Larimar Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Larimar Therapeutics Q1 Net Income USD -14.654 Million

May 09 (Reuters) - Larimar Therapeutics Q1 income from operations USD -16.734
million.
* Q1 basic EPS USD -0.27
* Q1 operating expenses USD 16.734 million

Recent news on Larimar Therapeutics

See all news